FindTrial
Sign In

TO STUDY COMBINED EFFECT OF BRAHMI GHRITA UTTARBASTI WITH ORAL ADMINISTRATION OF PUTRANJEEVAK CHURNA IN THE MANAGEMENT OF VANDHYATVA DUE TO ANOVULATION

A CLINICAL STUDY TO EVALUATE THE COMBINED EFFICACY OF BRAHMI GHRITA UTTARBASTI WITH ORAL ADMINISTRATION OF PUTRANJEEVAK CHURNA IN THE MANAGEMENT OF VANDHYATVA DUE TO ANOVULATION - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078056
Enrollment
30
Registered
2024-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Sponsors

Dr. Samiksha JAIN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: married diagnosed anovulatory cycle primary and secondary infertility

Exclusion criteria

Exclusion criteria: systemic disease like hypertension diabetes

Design outcomes

Primary

MeasureTime frame
combined efficacy of Brahmi Ghrita Uttarbasti with oral administration of Putranjeevak ChurnaTimepoint: 8th to 12 th day of three consicative cycles of mensturation 90 days—

Secondary

MeasureTime frame
understand the anovulatory cycle Timepoint: 3 months 8th to 12th day of menstrual cycle for 3 consecutive cycles churna for 90 days oral administration—

Countries

India

Contacts

Public ContactDr Samiksha Jain

Seth govindji Raoji Ayurved mahavidhyalaya , solapur

veena.jawale@sgrayurved.edu.in9028244410

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026